Alfasigma’s Ashraf Virmani presenteert poster op #SSIEM2022
24 augustus 2022
Van 30 augustus tot 2 september vindt het SSIEM Symposium
Actueel & Media / Actueel
Actueel
ALFASIGMA ANNOUNCES THE AGREEMENT FOR THE ACQUISITION OF 100% OF SOFAR, ITALIAN PHARMACEUTICAL COMPANY
8 augustus 2022
ALFASIGMA S.p.A. has signed an agreement to acquire the entire share
#LeaveYourMark with Alfasigma!
1 juli 2022
#LeaveYourMark will explore some of our key task: Improving patients'
Dag van de Hielprik 2022
28 juni 2022
De Neonatale Hielprik Screening (NHS) is in 1974 in Nederland
Website van Alfasigma Nederland is nu live!
21 april 2022
Hier vind u informatie over onze producten en binnenkort ook
Change at the top of Alfasigma. Pier Vincenzo Colli leaves, new CEO will be Francesco Balestrieri.
8 oktober 2021
Chief Executive Officer of Alfasigma, Pier Vincenzo Colli, has decided to